Christopher Raymond
Stock Analyst at Raymond James
(3.14)
# 2,620
Out of 4,655 analysts
871
Total ratings
45%
Success rate
2%
Average return
Main Sectors:
Stocks Rated by Christopher Raymond
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGP SpyGlass Pharma | Initiated Coverage: Buy | $39 | $25.78 | +51.28% | 1 | Aug 14, 2026 | |
| SION Sionna Therapeutics | Downgraded: Hold | n/a | $5.91 | - | 1 | Aug 10, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Buy | $105 | $66.64 | +57.56% | 87 | Aug 7, 2026 | |
| ARDX Ardelyx | Maintained: Buy | $19 → $15 | $4.06 | +269.46% | 42 | Aug 7, 2026 | |
| TYRA Tyra Biosciences | Maintained: Buy | n/a | $26.22 | - | 8 | Jul 17, 2026 | |
| CLYM Climb Bio | Maintained: Buy | n/a | $17.44 | - | 3 | Jun 24, 2026 | |
| BHVN Biohaven | Maintained: Buy | n/a | $14.46 | - | 22 | Jun 24, 2026 | |
| AKTS Aktis Oncology | Initiated Coverage: Buy | $40 | $24.72 | +61.81% | 1 | Jun 16, 2026 | |
| ALMS Alumis | Maintained: Buy | $46 | $25.50 | +80.39% | 2 | Mar 27, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Buy | $723 → $870 | $805.93 | +7.95% | 114 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $37.87 | +58.44% | 20 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $4.98 | +402.01% | 2 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $47 | $6.74 | +597.33% | 1 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $6.21 | +109.34% | 6 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $142 → $123 | $116.49 | +5.59% | 5 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 → $29 | $13.77 | +110.60% | 11 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $419.38 | - | 78 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $3.96 | +480.81% | 14 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $533 → $401 | $515.55 | -22.22% | 26 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $5.92 | n/a | 6 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 | $26.13 | n/a | 58 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $4 | $15.95 | n/a | 6 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 | $120.73 | n/a | 5 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $220 → $227 | $250.33 | n/a | 84 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $75 | $1.81 | n/a | 21 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $307 → $315 | $209.15 | n/a | 91 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $9.94 | n/a | 19 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $56 | $33.63 | n/a | 11 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $0.0002 | n/a | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 → $8 | $1.97 | n/a | 24 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 | $58.63 | n/a | 1 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $0.86 | n/a | 22 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $600 | $987.84 | n/a | 1 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $22 | $63.53 | n/a | 1 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $1.59 | n/a | 1 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $28 | $0.6625 | n/a | 5 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $31.31 | n/a | 1 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $6.81 | n/a | 6 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $75 → $30 | $9.10 | n/a | 5 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $6 | $1.15 | n/a | 20 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $42.45 | n/a | 12 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.49 | n/a | 4 | Mar 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $36.46 | n/a | 1 | Apr 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.98 | n/a | 6 | Aug 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $42 → $101 | - | n/a | 2 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.0016 | n/a | 6 | Mar 19, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $3 → $6 | $2.97 | n/a | 3 | Feb 29, 2012 |
SpyGlass Pharma
Aug 14, 2026
Initiated Coverage: Buy
Price Target: $39
Current: $25.78
Upside: +51.28%
Sionna Therapeutics
Aug 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $5.91
Upside: -
BioMarin Pharmaceutical
Aug 7, 2026
Maintained: Buy
Price Target: $105
Current: $66.64
Upside: +57.56%
Ardelyx
Aug 7, 2026
Maintained: Buy
Price Target: $19 → $15
Current: $4.06
Upside: +269.46%
Tyra Biosciences
Jul 17, 2026
Maintained: Buy
Price Target: n/a
Current: $26.22
Upside: -
Climb Bio
Jun 24, 2026
Maintained: Buy
Price Target: n/a
Current: $17.44
Upside: -
Biohaven
Jun 24, 2026
Maintained: Buy
Price Target: n/a
Current: $14.46
Upside: -
Aktis Oncology
Jun 16, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $24.72
Upside: +61.81%
Alumis
Mar 27, 2026
Maintained: Buy
Price Target: $46
Current: $25.50
Upside: +80.39%
Regeneron Pharmaceuticals
Jan 30, 2026
Maintained: Buy
Price Target: $723 → $870
Current: $805.93
Upside: +7.95%
Jan 26, 2026
Maintained: Buy
Price Target: $60
Current: $37.87
Upside: +58.44%
Jan 13, 2026
Maintained: Buy
Price Target: $25
Current: $4.98
Upside: +402.01%
Dec 2, 2025
Initiated Coverage: Buy
Price Target: $47
Current: $6.74
Upside: +597.33%
Nov 25, 2025
Maintained: Buy
Price Target: $13
Current: $6.21
Upside: +109.34%
Nov 14, 2025
Maintained: Buy
Price Target: $142 → $123
Current: $116.49
Upside: +5.59%
Oct 20, 2025
Initiated Coverage: Buy
Price Target: $26 → $29
Current: $13.77
Upside: +110.60%
Oct 10, 2025
Maintained: Hold
Price Target: n/a
Current: $419.38
Upside: -
Sep 16, 2025
Maintained: Buy
Price Target: $23
Current: $3.96
Upside: +480.81%
Sep 2, 2025
Initiated Coverage: Hold
Price Target: $533 → $401
Current: $515.55
Upside: -22.22%
Feb 18, 2025
Maintained: Buy
Price Target: $13
Current: $5.92
Upside: n/a
Feb 14, 2025
Maintained: Buy
Price Target: $140
Current: $26.13
Upside: n/a
Feb 11, 2025
Downgraded: Hold
Price Target: $20 → $4
Current: $15.95
Upside: n/a
Feb 10, 2025
Maintained: Buy
Price Target: $42
Current: $120.73
Upside: n/a
Jan 27, 2025
Rated: Buy
Price Target: $220 → $227
Current: $250.33
Upside: n/a
Jan 27, 2025
Rated: Buy
Price Target: $75
Current: $1.81
Upside: n/a
Oct 30, 2024
Maintained: Buy
Price Target: $307 → $315
Current: $209.15
Upside: n/a
Oct 23, 2024
Rated: Buy
Price Target: $20
Current: $9.94
Upside: n/a
Oct 23, 2024
Rated: Buy
Price Target: $56
Current: $33.63
Upside: n/a
Sep 16, 2024
Rated: Buy
Price Target: $10
Current: $0.0002
Upside: n/a
Aug 9, 2024
Rated: Buy
Price Target: $21 → $8
Current: $1.97
Upside: n/a
Oct 25, 2023
Maintained: Buy
Price Target: $58
Current: $58.63
Upside: n/a
Oct 25, 2023
Maintained: Buy
Price Target: $4
Current: $0.86
Upside: n/a
Oct 25, 2023
Maintained: Buy
Price Target: $600
Current: $987.84
Upside: n/a
Jul 24, 2023
Rated: Hold
Price Target: $22
Current: $63.53
Upside: n/a
Apr 25, 2023
Maintained: Buy
Price Target: $14
Current: $1.59
Upside: n/a
Nov 22, 2022
Maintained: Hold
Price Target: $28
Current: $0.6625
Upside: n/a
Jul 25, 2022
Initiated Coverage: Buy
Price Target: $28
Current: $31.31
Upside: n/a
May 23, 2022
Maintained: Buy
Price Target: $3
Current: $6.81
Upside: n/a
May 18, 2022
Maintained: Hold
Price Target: $75 → $30
Current: $9.10
Upside: n/a
May 11, 2021
Maintained: Hold
Price Target: $7 → $6
Current: $1.15
Upside: n/a
Apr 13, 2021
Maintained: Buy
Price Target: $8
Current: $42.45
Upside: n/a
Mar 27, 2020
Maintained: Buy
Price Target: n/a
Current: $7.49
Upside: n/a
Apr 18, 2019
Maintained: Hold
Price Target: n/a
Current: $36.46
Upside: n/a
Aug 7, 2017
Rated: Hold
Price Target: n/a
Current: $3.98
Upside: n/a
Mar 31, 2015
Downgraded: Hold
Price Target: $42 → $101
Current: -
Upside: n/a
Mar 19, 2013
Maintained: Hold
Price Target: n/a
Current: $0.0016
Upside: n/a
Feb 29, 2012
Upgraded: Buy
Price Target: $3 → $6
Current: $2.97
Upside: n/a